We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Bioelectronic medicine company Cala has presented real world evidence for validating the long-term safety and efficacy of its Cala TAPS (transcutaneous afferent patterned stimulation) therapy for essential tremor
Stryker has announced the launch of its Q Guidance system for spine applications which is integrated with the Spine Guidance software to increase surgical planning and navigation capability.
Australia-based cancer care provider Icon Group will participate in the Varian-sponsored HyperArc registry, designed to collect patient data to inform and expand treatment options for patients with brain
Becton, Dickinson and Company (BD) and CerTest Biotec have commercially launched their new molecular polymerase chain reaction (PCR) assay for the monkeypox virus for the US and global
Enzo Biochem, a leading biosciences and diagnostics company, today announced the launch of the AMPIVIEW line, a breakthrough RNA gene expression platform powered by Enzo’s LoopRNA in situ
Smith+Nephew, the global medical technology company, today announces the first cases for revision knee replacement utilizing its CORI◊ Surgical System. Dr. Thorsten Seyler of Duke University performed the
ClearPoint Neuro said that its Swedish partner Clinical Laserthermia Systems (CLS) has secured the US Food and Drug Administration (FDA) 510(k) clearance for its neuro laser therapy system.
Leuko, a startup spun out from Massachusetts Institute of Technology (MIT), has raised $5m in a Series A funding round for its at-home non-invasive white blood cell (WBC)
Biotech and medical AI innovator Surge announced a $2.6 million round co-led by HCVC, a global early-stage fund dedicated to high-potential technology startups, and Boutique Venture Partners, a leading fund based in
iMediSync announced that iSyncWave, the company’s medical device EEG scanner, has been granted 510k clearance from the US Food and Drug Administration (FDA) on August 10th. According to iMediSync, iSyncWave is a